Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYMS | P04818 | 19/20 | 0.53 |
| ▸ | DHFR | P00374 | 2/20 | 0.53 |
| ▸ | FOLR2 | P14207 | 1/20 | 0.53 |
| ▸ | FOLR1 | P15328 | 1/20 | 0.53 |
| ▸ | GART | P22102 | 1/20 | 0.53 |
| ▸ | ATIC | P31939 | 1/20 | 0.53 |
| ▸ | SHMT1 | P34896 | 1/20 | 0.53 |
| ▸ | SLC19A1 | P41440 | 1/20 | 0.53 |
| ▸ | FRK | P42685 | 1/20 | 0.53 |
| ▸ | SLC46A1 | Q96NT5 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12905188 | 0.88 | TYMS (0.59) | TYMSDHFRFOLR2FOLR1GART | |
| SCHEMBL15145417 | 0.86 | GART (0.72) | TYMSDHFRFOLR2FOLR1GART | |
| SCHEMBL16582197 | 0.83 | TYMS (0.70) | TYMSDHFRFOLR2FOLR1GART | |
| SCHEMBL21558192 | 0.83 | TYMS (0.64) | TYMSDHFRFOLR2FOLR1GART | |
| SCHEMBL24629271 | 0.82 | TYMS (0.61) | TYMSDHFRFOLR2FOLR1GART | |
| SCHEMBL21558193 | 0.82 | GART (0.73) | TYMSDHFRFOLR2FOLR1GART | |
| SCHEMBL15145419 | 0.82 | GART (0.73) | TYMSDHFRFOLR2FOLR1GART | |
| SCHEMBL13508147 | 0.82 | TYMS (0.55) | TYMSDHFRFOLR2FOLR1GART | |
| SCHEMBL19933020 | 0.80 | GART (0.70) | TYMSDHFRFOLR2FOLR1GART | |
| SCHEMBL20908952 | 0.80 | TYMS (0.56) | TYMSDHFRFOLR2FOLR1GART |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3566719-A1 | COMPOSITIONS AND METHODS FOR TREATMENT OF AUTOIMMUNE AND OTHER DISEASES | Cerulean Pharma Inc. (US) | 2019-11-13 | — | — | EP | disclosed |